These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37774942)

  • 1. Atomoxetine and reward size equally improve task engagement and perceptual decisions but differently affect movement execution.
    Kaduk K; Henry T; Guitton J; Meunier M; Thura D; Hadj-Bouziane F
    Neuropharmacology; 2023 Dec; 241():109736. PubMed ID: 37774942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine's effect on impulsive action in adulthood.
    Silveira MM; Murch WS; Clark L; Winstanley CA
    Behav Pharmacol; 2016 Jun; 27(4):350-63. PubMed ID: 26650252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research.
    Higgins GA; Silenieks LB; MacMillan C; Thevarkunnel S; Parachikova AI; Mombereau C; Lindgren H; Bastlund JF
    Front Pharmacol; 2020; 11():427. PubMed ID: 32390829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of reaction time distributions to study attention in male rats: the effects of atomoxetine and guanfacine.
    Redding ZV; Chawla P; Sabol KE
    Psychopharmacology (Berl); 2019 Dec; 236(12):3579-3592. PubMed ID: 31321458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of d-amphetamine and atomoxetine on measures of impulsive action and choice.
    Higgins GA; Brown M; MacMillan C; Silenieks LB; Thevarkunnel S
    Pharmacol Biochem Behav; 2021 Aug; 207():173220. PubMed ID: 34175329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomoxetine modulates the contribution of low-level signals during free viewing of natural images in rhesus monkeys.
    Reynaud AJ; Blini E; Koun E; Macaluso E; Meunier M; Hadj-Bouziane F
    Neuropharmacology; 2021 Jan; 182():108377. PubMed ID: 33137343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomoxetine improves attentional orienting in a predictive context.
    Reynaud AJ; Froesel M; Guedj C; Ben Hadj Hassen S; Cléry J; Meunier M; Ben Hamed S; Hadj-Bouziane F
    Neuropharmacology; 2019 May; 150():59-69. PubMed ID: 30876931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal Activity in the Premotor Cortex of Monkeys Reflects Both Cue Salience and Motivation for Action Generation and Inhibition.
    Giamundo M; Giarrocco F; Brunamonti E; Fabbrini F; Pani P; Ferraina S
    J Neurosci; 2021 Sep; 41(36):7591-7606. PubMed ID: 34330772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic contributions to cue-driven risk-taking and impulsivity.
    Chernoff CS; Hynes TJ; Winstanley CA
    Psychopharmacology (Berl); 2021 Jul; 238(7):1765-1779. PubMed ID: 33649970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-HT
    Higgins GA; Brown M; St John J; MacMillan C; Silenieks LB; Thevarkunnel S
    Neuropharmacology; 2020 Jun; 170():108064. PubMed ID: 32222404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural signals in the monkey ventral striatum related to motivation for juice and cocaine rewards.
    Bowman EM; Aigner TG; Richmond BJ
    J Neurophysiol; 1996 Mar; 75(3):1061-73. PubMed ID: 8867118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.
    Baarendse PJ; Vanderschuren LJ
    Psychopharmacology (Berl); 2012 Jan; 219(2):313-26. PubMed ID: 22134476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers.
    Marquand AF; De Simoni S; O'Daly OG; Williams SC; Mourão-Miranda J; Mehta MA
    Neuropsychopharmacology; 2011 May; 36(6):1237-47. PubMed ID: 21346736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists.
    Fernando AB; Economidou D; Theobald DE; Zou MF; Newman AH; Spoelder M; Caprioli D; Moreno M; Hipólito L; Aspinall AT; Robbins TW; Dalley JW
    Psychopharmacology (Berl); 2012 Jan; 219(2):341-52. PubMed ID: 21761147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomoxetine improves hippocampal cell proliferation but not memory in Doxorubicin-treated adult male rats.
    Salman A; El Beltagy M; Shatarat A; Alzghoul L; Oweis L; Al Antary N; Al Fegie S; Mohsen M; Salman S
    Vet Med Sci; 2020 Nov; 6(4):1017-1024. PubMed ID: 32342640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat.
    Robinson ES; Eagle DM; Mar AC; Bari A; Banerjee G; Jiang X; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2008 Apr; 33(5):1028-37. PubMed ID: 17637611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making.
    Broos N; Loonstra R; van Mourik Y; Schetters D; Schoffelmeer AN; Pattij T; De Vries TJ
    Addict Biol; 2015 Jul; 20(4):714-23. PubMed ID: 25056833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomoxetine modulates the relationship between perceptual abilities and response bias.
    Guedj C; Reynaud A; Monfardini E; Salemme R; Farnè A; Meunier M; Hadj-Bouziane F
    Psychopharmacology (Berl); 2019 Dec; 236(12):3641-3653. PubMed ID: 31384989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Makes You Go Faster?: The Effect of Reward on Speeded Action under Risk.
    Chen XJ; Kwak Y
    Front Psychol; 2017; 8():1057. PubMed ID: 28694787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder.
    Walker DJ; Mason O; Clemow DB; Day KA
    Postgrad Med; 2015; 127(7):686-701. PubMed ID: 26343377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.